China Universal Asset Management Company’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $408K | Buy |
29,178
+50
| +0.2% | +$699 | 0.04% | 255 |
|
|
2025
Q1 | $396K | Sell |
29,128
-1,389
| -5% | -$18.9K | 0.04% | 263 |
|
|
2024
Q4 | $622K | Buy |
30,517
+2,982
| +11% | +$60.8K | 0.06% | 222 |
|
|
2024
Q3 | $802K | Buy |
27,535
+10,782
| +64% | +$314K | 0.09% | 159 |
|
|
2024
Q2 | $389K | Sell |
16,753
-9,968
| -37% | -$231K | 0.05% | 168 |
|
|
2024
Q1 | $548K | Buy |
26,721
+10,740
| +67% | +$220K | 0.07% | 175 |
|
|
2023
Q4 | $343K | Buy |
15,981
+12,455
| +353% | +$267K | 0.07% | 166 |
|
|
2023
Q3 | $72.7K | Buy |
3,526
+1,732
| +97% | +$35.7K | 0.02% | 213 |
|
|
2023
Q2 | $52.9K | Sell |
1,794
-57
| -3% | -$1.68K | 0.02% | 187 |
|
|
2023
Q1 | $42.6K | Buy |
1,851
+471
| +34% | +$10.9K | 0.01% | 160 |
|
|
2022
Q4 | $38.4K | Buy |
1,380
+225
| +19% | +$6.26K | 0.02% | 145 |
|
|
2022
Q3 | $35K | Buy |
+1,155
| New | +$35K | 0.01% | 132 |
|